Obstructive Sleep Apnea (OSA) is one of the most underdiagnosed yet highest-cost chronic conditions, driving cardiovascular, metabolic and neurocognitive comorbidities. Traditional sleep labs cannot keep pace with demand, leading to long delays, fragmented care, and rising costs. Today, regulated digital tools are shifting OSA management from episodic diagnosis to proactive, continuous, home-based care. This guide benchmarks 10 certified solutions that can reduce diagnostic delays from months to days, lower per-patient costs by up to 60%, and unlock new models for pharma, medtech and digital health innovators.